UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 1, 2005
ORTHOVITA, INC.
(Exact Name of Registrant Specified in Charter)
| | | | |
| Pennsylvania | | 0-24517 | | 23-2694857 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | |
45 Great Valley Parkway Malvern, Pennsylvania | | 19355 |
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone, including area code: (610) 640-1775
Not applicable.
(Former Name and Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On April 1, 2005, Orthovita, Inc. announced that Joseph Harris joined its Board of Directors (the “Board”). On February 23, 2005, the Board voted to increase the size of the Board from six to seven members and appointed Joseph Harris to serve as director, effective as of April 1, 2005, and fill the vacancy created by such increase. The appointment was based on the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Committee”). Mr. Harris was recommended to the Committee by members of Board and has been determined to be independent, as independence is currently defined in the Nasdaq listing standards.
The Company issued a press release on April 1, 2005 announcing the appointment of Mr. Harris to the Board, a copy of which is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
| 99.1 | Press Release, dated April 1, 2005 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| ORTHOVITA, INC. |
| |
| By: | | /s/ Joseph M. Paiva
|
| | | Joseph M. Paiva |
| | | Chief Financial Officer |
Dated: April 1, 2005
Exhibit Index
| | |
Exhibit No.
| | Description
|
| 99.1 | | Press Release, dated April 1, 2005 |
